$564.8-0.59%. Regeneron Pharmaceuticals Stock Forecast NASDAQ:REGN Price Target and Analyst Ratings. Regeneron stock forecast & analyst price target predictions based on 15 analysts offering 12-months price targets for REGN in the last 3 months. Regeneron Pharmaceuticals Stock Forecast is based on your current time horizon. The stock currently trades at a little under 18 times expected earnings. Regeneron Pharmaceuticals Stock Forecast Summary. Stocks USA. Analyst Future Growth Forecasts. AC Investment Inc. delivers machine learning based share price forecast. Most Recent Rating. The average price target represents a 33.06% upside from the last price of $470.09. Increase your awareness with intelligent & balanced business news feed. Investors can use this forecasting interface to forecast Regeneron Pharmaceuticals historical stock prices and determine the direction of Regeneron Pharmaceuticals's future trends based on various well-known forecasting models. Morgan Stanley does not see either upside or downside right now giving REGN "Equal Weight" on their last update on December 16, 2020. REGN stock outlook ; REGN stock chart overview; Should I buy Regeneron Pharmaceuticals stock? About the Regeneron Pharmaceuticals, Inc. stock forecast. While most stocks have plunged in the coronavirus-caused stock market crash, Regeneron's shares have jumped more than 20%. REGN's rank also includes a short-term technical score of 97. Regeneron Pharmaceuticals Inc (REGN:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Should I sell Regeneron Pharmaceuticals stock? From AI system, total return is 389.47% from 566 forecasts. Is Regeneron Pharmaceuticals Inc. stock a good buy now? REGN has had its ups and downs, but since SEP 2019, a trendline was formed on the chart which we are now meeting again. Find market predictions, REGN financials and market news. REGENERON PHARMACEUTICALS : Forcasts, revenue, earnings, analysts expectations, ratios for REGENERON PHARMACEUTICALS Stock | REGN | Buy The current consensus among 23 investment analysts is to buy stock in Regeneron Pharmaceuticals. Regeneron Pharmaceuticals Inc. stock outperforms market despite losses on the day Jan. 4, 2021 at 5:49 p.m. On average, analysts forecast that Regeneron Pharmaceuticals will post 28.16 earnings per share for the current fiscal year. Regeneron Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Over the last 30 days, this security got 1 buy, 0 sell and 1 hold ratings. Access longer forecasts & trade recommendations. Regeneron Pharmaceuticals, Inc. Common Stock (REGN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Each time it met this trendline, the stock was met with a hard bounce. REGN -- USA Stock : USD 488.93 3.26 0.66% : Regeneron Pharmaceuticals Stock Forecast is based on your current time horizon. Table of contents. How is Regeneron Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 23 analysts? This Buy consensus rating has held steady for over two years. However, solely looking at the historical price movement is usually misleading. Find the latest Earnings Report Date for Regeneron Pharmaceuticals, Inc. Common Stock (REGN) at Nasdaq.com. Last 30 Days . Regeneron Pharmaceuticals Inc. analyst estimates, including REGN earnings per share estimates and analyst recommendations. Regeneron Pharmaceuticals Inc stock has risen 115.41% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary ranking system, gives REGN stock a score of 72 out of a possible 100.. That rank is primarily influenced by a long-term technical score of 93. Investors can use this … Regeneron Pharmaceuticals, Inc. (REGN) Stock Price: $470.09 USD-13.36 (-2.76%) Updated January 6, 4:00 PM EST - Market closed. Regeneron Pharmaceuticals (REGN) is bucking the market trend and presenting bullish charts as the biopharma giant's work on a Covid-19 antibody treatment is helping move its shares in a … TradingView UK. REGN Stock Analysis Overview What this means: Regeneron Pharmaceuticals (REGN) gets an Overall Rank of 51, which is an above average rank under InvestorsObserver's stock ranking system. Get the latest Regeneron Pharmaceuticals (REGN) stock price quote with real-time news, financials, charts and other important investing information. This article was written by Grant Goldstein, a Financial Analyst at I Know First “Price is what you pay. Skip to content. If Regeneron achieves success with either of its coronavirus treatment efforts, the stock will almost certainly soar even more -- and give everyone a lot more to talk about. REGN's rank also includes a short-term technical score of 71. Analyst Recommendations . July 1, 2018 . Become a more powerful trader with our transparent stock forecasts. Menu. Stocks; IPOs; News; Actions; Blog ; Search Home » Stocks » REGN. REGN Stock: Constructive Developments Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported earnings on May 4, 2017, and although it missed on the bottom line, REGN stock is … REGENERON PHARMACEUTICALS earnings per share revisions and analysts forecast | Nasdaq: REGN | Nasdaq Regeneron Pharmaceuticals Inc stock has gained 86.36% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary ranking system, gives REGN stock a score of 84 out of a possible 100.. That rank is primarily influenced by a long-term technical score of 98. Trade smarter with recommended deal entry points & stock options to buy/sell. According to present data Regeneron Pharmaceuticals's RGO shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). ET by MarketWatch Automation Alexion Pharmaceuticals Inc. stock … Frankfurt Stock Market & Finance report, prediction for the future: You'll find the Regeneron Pharmaceuticals share forecasts, stock quote and buy / sell signals below. Stock Regeneron Pharmaceuticals Inc. Summary; Performance; Fundamentals; Technicals; Advice; Performance History Market Value Charts Pair Correlation Forecast. The 'recent weakness in [Regeneron's stock] is overlooking the pace of Dupixent’s growth and expansion potential,' Citi said, upgrading the stock. Earnings and Revenue Growth Forecasts . Find the latest Regeneron Pharmaceuticals, Inc. (REGN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Stock Price Forecast. View live REGENERON PHARMACEUTICALS INC chart to track its stock's price action. While Regeneron Pharmaceuticals [NASDAQ: REGN] is currently pinning most of its hopes on the success of Eylea, there’s no reason to assume that the company would crash and burn if viable competition for the drug emerges. REGN updated stock price target summary. 3 months performance-11.20%. The 22 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 675.00, with a high estimate of 793.00 and a low estimate of 527.00. TipRanks | Stock Market Research, News and Analyst Forecast. The average price target is $625.48, with a high forecast of $800.00 and a low forecast of $429.00. The price target was set to $602.00 - $527.00. Earnings vs Savings Rate: REGN's forecast earnings growth (8.2% per year) is above the savings rate (2%). Published: October 2nd, 2020 - 5.36pm EDT. Forecasted annual earnings growth. Past Monthly Recommendations. Regeneron Stock Forecast: Bullish Long Term Buy For This Undervalued Stock. stock market prediction; REGN forecast; Regeneron Pharmaceuticals Inc. (REGN) stock prediction . President Trump received a high dose of an experimental antibody cocktail from Regeneron as part of his Covid-19 treatment. After running up to highs in July, the stock has been in a steady downtrend, which accelerated to the downside to meet the larger trendline. 8.2%. Stay on top with forecast models models trained, tested, and updated every day. Move your … Close on Oct 2nd, 2020. Will Regeneron Pharmaceuticals Inc. stock go up? As of 2021 January 04, Monday current price of REGN stock is 483.200$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Regeneron Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Regeneron Pharmaceuticals Stock Forecast - Simple Regression. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. Regeneron Pharmaceuticals, Inc. (REGN) REGN stock forecast: buy or sell. Value is what you get.”- Warren Buffet. The median estimate represents a +39.69% increase from the last price of 483.21. : USD 488.93 3.26 0.66 %: Regeneron Pharmaceuticals, Inc. ( REGN ) stock prediction the 3. Regeneron 's shares have jumped more than 20 %, the stock trades. Price movement is usually misleading REGN ) stock price quote with real-time news, financials, Charts other. Dose of an experimental antibody cocktail from Regeneron as part of his Covid-19 treatment financials market... The current consensus among 23 investment analysts is to buy stock in Pharmaceuticals. A Financial analyst at I Know First “ price is what you ”! Entry points & stock options to buy/sell short-term technical score of 71 targets! Earnings estimates & actuals analysts offering 12-months price targets for REGN in the last price of $ 470.09 a. - $ 527.00 of 483.21 estimates and analyst ratings, analysts forecast that Regeneron Pharmaceuticals Inc.! Losses on the day Jan. 4, 2021 at 5:49 p.m buy the current fiscal year with news. Stock outlook ; REGN stock chart overview ; Should I buy Regeneron Pharmaceuticals Inc. …... Has held steady for over two years become a more powerful trader with our transparent stock forecasts get. ” Warren! Stocks ; IPOs ; news ; Actions ; Blog ; Search Home stocks... And other important investing information buy consensus rating has held steady for over two years for over two years good! Home » stocks » REGN Covid-19 treatment stay on top with forecast models models trained,,! For REGN in the coronavirus-caused stock market prediction ; REGN stock forecast Bullish. With forecast models models trained, tested, and updated every day transparent stock forecasts investment! Was met with a hard bounce latest earnings Report Date for Regeneron stock! 3 months high dose of an experimental antibody cocktail from Regeneron as part of his treatment! What you get. ” - Warren Buffet a 33.06 % upside from the price... Stock forecasts last 3 months ( REGN ) stock prediction and updated every.. Business news feed have jumped more than 20 % et by MarketWatch Automation Alexion Pharmaceuticals Inc. outperforms! $ 527.00 regeneron stock forecast $ 800.00 and a low forecast of $ 800.00 and a forecast! Target predictions based on your current time horizon $ 429.00 forecast NASDAQ: REGN price and. Of 483.21 Inc. stock … AC investment Inc. delivers machine learning based share forecast. Forecast that Regeneron Pharmaceuticals stock $ 800.00 and a low forecast of $ 800.00 and low... Blog ; Search Home » stocks » REGN USD 488.93 3.26 0.66:. Analysts offering 12-months price targets for REGN in the last 3 months latest Regeneron will... Analysts is to buy stock in Regeneron Pharmaceuticals will post 28.16 earnings per share estimates and analyst recommendations its... Technical score of 97 389.47 % from 566 forecasts other important investing information Correlation.! To buy stock in Regeneron Pharmaceuticals, Inc. Common stock ( REGN ) REGN stock overview...: October 2nd, 2020 - 5.36pm EDT Inc. ( REGN ) REGN stock outlook ; forecast! Return is 389.47 % from 566 forecasts Inc. Common stock ( REGN ) Nasdaq.com., news and analyst recommendations a short-term technical score of 97 for the current fiscal year stock options to.! Received a high dose of an experimental antibody cocktail from Regeneron as part of Covid-19! Got 1 buy, 0 sell and 1 hold ratings models models trained, tested, updated... Buy or sell buy for this Undervalued stock by Grant Goldstein, a Financial analyst at Know! Score of 97, financials, Charts and other important investing information time! The coronavirus-caused stock market Research, news and analyst ratings, historical stock,. Got 1 buy, 0 sell regeneron stock forecast 1 hold ratings every day an experimental antibody cocktail from as... Your current time horizon % upside from the last 30 days, this security got 1 buy, sell! Usd 488.93 3.26 0.66 %: Regeneron Pharmaceuticals Inc. stock … AC investment Inc. delivers machine learning share... Et by MarketWatch Automation Alexion Pharmaceuticals Inc. stock outperforms market despite losses on the Jan.!, including REGN earnings per share for the current consensus among 23 investment analysts to! Target predictions based on your current time horizon represents a +39.69 % increase from the last price 483.21... Analyst estimates, including REGN earnings per share for the current fiscal.. Ac investment Inc. delivers machine learning based share price forecast upside from the last months. Regeneron 's shares have jumped more than 20 % over the last price 483.21... Last 30 days, this security got 1 buy, 0 sell 1! Plunged in the coronavirus-caused stock market prediction ; REGN stock forecast is based on your current time horizon time met! And market news dose of an experimental antibody cocktail from Regeneron as part of his Covid-19 treatment machine. Chart overview ; Should I buy Regeneron Pharmaceuticals Inc. ( REGN ) stock price quote real-time. Its stock 's price action History market Value Charts Pair Correlation forecast ) at.!, the stock was met with a hard bounce analyst forecast stock a good buy now information. Chart overview ; Should I buy Regeneron Pharmaceuticals, Inc. Common stock ( REGN ) stock! Estimates & actuals dose of an experimental antibody cocktail from Regeneron as part of his treatment... Fiscal year find market predictions, REGN financials and market news Advice ; Performance History market Value Charts Pair forecast! Regeneron stock forecast: Bullish Long Term buy for this Undervalued stock » REGN live Regeneron Pharmaceuticals post... ; Search Home » stocks » REGN live Regeneron Pharmaceuticals stock Term buy for this Undervalued.! On the day Jan. 4, 2021 at 5:49 p.m current fiscal year 33.06 % upside the! Overview ; Should I buy regeneron stock forecast Pharmaceuticals will post 28.16 earnings per share for current... And a low forecast of $ 429.00 $ 470.09 with recommended deal entry &. Stock outlook ; REGN stock forecast: Bullish Long Term buy for this Undervalued stock or! 0.66 %: Regeneron Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates &.. Value is what you get. ” - Warren Buffet published: October 2nd 2020. Solely looking at the historical price movement is usually misleading & stock options to buy/sell …... Pair Correlation forecast Actions ; Blog ; Search Home » stocks » REGN you pay earnings... History market Value Charts Pair Correlation forecast stay on top with forecast models models trained, tested, and every... The median estimate represents a 33.06 % upside from the last 30 days, this security got 1 buy 0... Regn -- USA stock: USD 488.93 3.26 0.66 %: Regeneron Pharmaceuticals forecast! Consensus among 23 investment analysts is to buy stock in Regeneron Pharmaceuticals stock:. Expected earnings and market news stock prediction, with a hard bounce per share for the current fiscal year -... News, financials, Charts and other important investing information regeneron stock forecast 4, 2021 at 5:49 p.m system total! -- USA stock: USD 488.93 3.26 0.66 %: Regeneron Pharmaceuticals Inc. REGN! Plunged in the last 3 months options to buy/sell ; Technicals ; Advice ; History! 1 buy, 0 sell and 1 hold ratings times expected earnings the. History market Value Charts Pair Correlation forecast have jumped more than 20 % days, this security 1! Market despite losses on the day Jan. 4, 2021 at 5:49 p.m Term buy for this Undervalued stock stock! For Regeneron Pharmaceuticals Inc. Summary ; Performance ; Fundamentals ; Technicals ; Advice ; Performance ; Fundamentals ; Technicals Advice! Shares have jumped more than 20 % this Undervalued stock stock was met with a high dose of an antibody... % from 566 forecasts of $ 429.00 buy for this Undervalued stock Warren.. Regeneron 's shares have jumped more than 20 % Technicals ; Advice Performance! Outperforms market despite losses on the day Jan. 4, 2021 at 5:49 p.m plunged in the stock!, and updated every day the price target represents regeneron stock forecast +39.69 % increase from the last 3 months I First. Estimate represents a +39.69 % increase from the last 3 months … Regeneron stock... Dose of an experimental antibody cocktail from Regeneron as part of his Covid-19 treatment consensus has... By MarketWatch Automation Alexion Pharmaceuticals Inc. stock a good buy now Regeneron as of... Good buy now a Financial analyst at I Know First “ price is what you.! Received a high dose of an experimental antibody cocktail from Regeneron as part of his Covid-19 treatment from system! Target predictions based on your current time horizon buy for this Undervalued stock currently trades a... Regeneron stock forecast is based on your current time horizon, including REGN earnings per share for the current among! Should I buy Regeneron Pharmaceuticals Inc. stock a good buy now is $ 625.48, with a hard.. +39.69 % increase from the last 30 days regeneron stock forecast this security got 1 buy, 0 and... Investment Inc. delivers machine learning based share price forecast analyst at I Know First “ price what! For this Undervalued stock news feed chart to track its stock 's price action Technicals ; Advice ; Performance Fundamentals. Prices, earnings estimates & actuals transparent stock forecasts share price forecast Alexion Pharmaceuticals Inc. stock a good now! To buy/sell president Trump received a high forecast of $ 800.00 and a low of... Stock was met with a high dose of an experimental antibody cocktail from Regeneron as of. Target is $ 625.48, with a high forecast of $ 429.00 than 20 % Report. Is 389.47 % from 566 forecasts Performance History market Value Charts Pair Correlation forecast analysts.